- Directions for use
- Sincerus Florida. Adverse reactions
- Active, inactive
- NDC 72934-4146-8 MINOXIDIL USP 5% / PROGESTERONE USP 0.1% / TRETINOIN USP 0.025%. Solution 600 gm
-
INGREDIENTS AND APPEARANCE
MINOXIDIL 5% / PROGESTERONE 0.1% / TRETINOIN 0.025%
minoxidil 5% / progesterone 0.1% / tretinoin 0.025% solutionProduct Information Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:72934-4146 Route of Administration TOPICAL Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength MINOXIDIL (UNII: 5965120SH1) (MINOXIDIL - UNII:5965120SH1) MINOXIDIL 5 g in 100 g PROGESTERONE (UNII: 4G7DS2Q64Y) (PROGESTERONE - UNII:4G7DS2Q64Y) PROGESTERONE 0.1 g in 100 g TRETINOIN (UNII: 5688UTC01R) (TRETINOIN - UNII:5688UTC01R) TRETINOIN 0.025 g in 100 g Product Characteristics Color yellow Score Shape Size Flavor Imprint Code Contains Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:72934-4146-8 60 g in 1 BOTTLE, GLASS; Type 0: Not a Combination Product 05/07/2019 Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date unapproved drug other 05/07/2019 Labeler - Sincerus Florida, LLC (080105003) Establishment Name Address ID/FEI Business Operations Sincerus Florida, LLC 080105003 manufacture(72934-4146)